The strategy of immunologic control of HIV-1 with structured treatment interruptions (STIs)
- PMID: 12455230
- DOI: 10.2174/1568005013343236
The strategy of immunologic control of HIV-1 with structured treatment interruptions (STIs)
Abstract
Structured treatment interruptions (STIs) have evolved as an experimental approach of interrupting highly active antiretroviral therapy (HAART) similar to cycles of cancer chemotherapy in order to develop immune control of HIV-1. There are multiple, ongoing clinical trials examining interruptions in antiviral therapy with and without immune-based therapies. If successful in developing immune control, STIs may be clinically useful but require large scale clinical trials to prove their utility and safety.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical